Helena Xu has  a dual  academic  training in  Biomedical  Sciences and  Business  Management.  Prior  joining  Alira Health she  obtained  a Bachelor of  Sciences at  King’s   College   London,  UK,   where   she   also   worked as   a   research   assistant at  the   MRC of Neurodevelopmental Biology, UK. In 2015 she graduated with a Master in Science and Business Management at Utrecht University where she also conducted research in the field of gene therapy and nano medicine at the faculty of pharmaceutics. After her scientific career,  she began working as an  analyst at Alira in  projects  involving  technical  due  diligence,  market  analysis and  strategy development in the fields of immunotherapy, oral care and regenerative medicine.